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Abstract

Best Practices for Sepsis Patients: A Quality Improvement Project
Kevin Mark Smith Jr

Sepsis is a complication caused by the overwhelming and life-threatening response of the
body to an infection. Sepsis can lead to tissue damage, organ failure, and death (Center for
Disease Control and Prevention, 2016). Sepsis is the leading cause of death in U.S. hospitals.
Mortality from sepsis increases 8% for every hour that treatment is delayed. Each year, 258,000
people die from sepsis in the U.S. As many as 80% of sepsis deaths could be prevented with
rapid diagnosis and treatment (Sepsis Alliance, 2016). This project seeks to improve the ability
of the transfer unit to screen patients, improve early recognition and evaluation of best practices,
and provide a connection with a provider for care consultation. This potential significance of this
project is to improve patient outcomes including mortality, length of stay, and the assignment of
patients to the appropriate level of care through early recognition of sepsis and the
implementation of best practices. The use of a screening process to identify abnormal patient
variables including elevated serum lactate, decreased blood pressure, elevated respiratory rate,
and altered mental status can identify an increased likelihood of sepsis.
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Introduction
This project seeks to improve the process of care delivery for patients transferring to an
Academic Medical Center with a diagnosis of sepsis. The staff of the transfer unit at the
Academic Medical Center have recognized delays in transfers of patients with sepsis and
inconsistencies in sepsis care delivery by sending facilities. The planned project is designed to
improve the transfer process for these patients by implementing a new sepsis screening tool and
providing sepsis consultation for outside facilities upon a positive sepsis screen. The objective of
this project is to support timely evidence based care prior to patient transfer and subsequently
improve patient outcomes.
Background
Sepsis is a complication caused by the overwhelming and life-threatening response of the
body to an infection. Sepsis can lead to tissue damage, organ failure, and death (Center for
Disease Control and Prevention, 2016). Sepsis is the leading cause of death in U.S. hospitals.
Mortality from sepsis increases 8% for every hour that treatment is delayed. Each year, 258,000
people die from sepsis in the U.S. As many as 80% of sepsis deaths could be prevented with
rapid diagnosis and treatment (Sepsis Alliance, 2016). According to the CDC, when sepsis is
quickly recognized and treated, lives are saved. Healthcare providers are the critical link to
preventing, recognizing, and treating sepsis (U.S. Department of Health and Human Services,
2016).
Problem Statement
The Academic Medical Center of interest does not have an existing process for screening
and initiating treatment for patients diagnosed with sepsis prior to their transfer from a referring
facility. At present, incoming patients are accepted by Throughput RNs in the transfer unit after
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a series of questions are answered from outlying facility personnel, but there is not a sepsis
screen being utilized. The Academic Medical Center has transferred a total of 24,766 patients
from outside healthcare facilities from January 1, 2014 to April 30, 2017. These patient transfers
include a total of 2,147 (8.6%) patients that were diagnosed with sepsis present on arrival when
analyzed retrospectively. The early identification and treatment of these patients with sepsis may
have been enhanced with the implementation of a sepsis screening process. The implementation
a sepsis screening process in the transfer unit provides opportunities to improve patient care and
patient outcomes related to sepsis care.
Purpose of the Project
The purpose of the project is to identify patients with sepsis earlier with the goal
improving the outcomes of patients received as transfers from outside facilities. Early screening
of the patients and best practice implementation within the first hour of sepsis presentation is
critical to improving patient outcomes (Sepsis Alliance, 2016). The use of a sepsis screening
process by the Throughput RNs at transfer unit of an Academic Medical Center will help achieve
the purpose. This project seeks to improve the ability of the transfer unit to screen patients,
improve early recognition and evaluation of best practices, and provide a connection with a
provider for care consultation. These improvements will allow appropriate and timely care prior
to patient transfer during the critical first hour of recognition.

Significance of the Proposed Project
This potential significance of this project is to improve patient outcomes including
mortality, length of stay, and the assignment of patients to the appropriate level of care through
early recognition of sepsis and the implementation of best practices. The use of a screening
process to identify abnormal patient variables including elevated serum lactate, decreased blood
2

pressure, elevated respiratory rate, and altered mental status can identify an increased likelihood
of sepsis. Thus, with this early recognition care providers can intervene earlier and subsequently
improve patient outcomes.
Literature Review and Synthesis
Two separate literature searches were conducted for the completion of this literature
review. The first search utilized the following databases, CINAHL, MEDLINE, Academic
Search Complete, and Healthsource: Nursing and Academic Edition. Search keywords included
sepsis and clinical protocols as subject terms. This search resulted in 493 studies. To be
including in this review the paper had to address the following: timeliness of the intervention,
intervention included sepsis protocol or bundle, new onset of sepsis, peer-reviewed, English
language, and adults. Papers were excluded if: intervention did not include a full sepsis bundle or
protocol and disease specific related sepsis treatment. This resulted in a total of 42 paper to be
reviewed.
A second review was completed because topics known to the author, such as mortality
and patient outcomes, were not found in the first review. Using the same search criteria, the
search keywords of sepsis protocols and mortality were used. This search resulted in 1283
papers. After applying the same inclusion and exclusion criteria and the removal of duplicates,
10 additional papers were included.
Thus, the total number of papers in the review was 52. After a review of these papers,
three major themes emerged including; the issue of sepsis in hospitals, the impact of sepsis
screening on recognition of sepsis and the implementation of best practices, and evidence based
practices for sepsis care.
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Issue of Sepsis in Hospitals
The diagnosis and management of patients with sepsis is an important consideration for
healthcare organizations. Sepsis is a complication caused by the body’s overwhelming and lifethreatening response to infection, which can lead to tissue damage, organ failure, and death
(CDC, 2016). Sepsis is difficult to predict, diagnose, and treat. Patients who develop sepsis have
an increased risk of complications and death and face higher healthcare costs and longer
treatment. From 1999–2014, the CDC found that a total of 2,470,666 decedents (6% of all
deaths) had sepsis listed among the causes of death (CDC, 2016). Many healthcare organizations
have acted to improve survival rates and standardize sepsis care. However, sepsis continues to
burden patient populations and continued efforts to improve healthcare organization’s ability to
care for these patients is necessary.
Impact of Sepsis Screening on Recognition of Sepsis and Implementation of Best Practices
The literature in this review revealed mortality rates of healthcare organization between
35.1% and 61.1% in sepsis patients prior to implementing a sepsis screening and treatment
process. Following the implementation of sepsis processes each organization observed decreases
in mortality. One retrospective cohort study found a decreased mortality from 43.8% to 18.2%
(Trzeciak et al., 2006). Another study found decrease in mortality rates from 29.7% to 21.1%
(Jones et al., 2015). A third study found a decreased mortality rate from 39.5% to 20.8%
(Ngyuyen et al., 2016).
This review of literature found that many healthcare organizations were able to improve
the ability to recognize sepsis in early onset with screening tools, thus improve the efficiency of
best practice intervention delivery. Twelve studies in the literature review observed statistically
4

significant decreases in the length of time for care providers to recognize sepsis via sepsis
screening tools (Bruce et al., 2015; Dellinger et al., 2008; Focht et al., 2009; Gaieski et al., 2010;
Miguel-Yanes, Andueza-Lillo, González-Ramallo, Pastor, & Muñoz, 2006; Hayden et al., 2016;
Patel et al., 2010; Puskarich et al., 2011; Tromp et al., 2010; Trzeciak et al., 2006; Westfall et al.,
2011; Yealy et al., 2014). Each study that observed an increase in recognition also reported a
statistically significant decrease in the amount of time to delivery best practices interventions
including fluid boluses, antibiotic administration, serum lactate level draws, and blood culture
draws(Bruce et al., 2015; Dellinger et al., 2008; Focht et al., 2009; Gaieski et al., 2010; MiguelYanes et al., 2006; Hayden et al., 2016; Patel et al., 2010; Puskarich et al., 2011; Tromp et al.,
2010; Trzeciak et al., 2006; Westfall et al., 2011; Yealy et al., 2014).
One study observed the time to antibiotics for patients with severe sepsis and septic shock
was significantly reduced in the post–BPA cohort from 61.5 minutes to 29.5 minutes. That same
study observed an improved time to receive antibiotics within 60 minutes from 48.6% to 76.7%
(Narayanan et al., 2005). A study witnessed improvements in overall time to cultures, first dose
of antibiotics, and transfers out of the ED to the ICU due to the initiation of the bundle (Patel,
Roderman, Gehring, Saad, & Bartek, 2010). Another study observed the median time to initial
antibiotic administration was reduced significantly, by 27 minutes (Bruce et al., 2015). An
international study found that the mean time elapsed between the identification of the first signs
of sepsis risk and the detection of sepsis was longer in phase I than in phase II (34 vs 11 hours; P
< .001) (Westfall et al., 2011). The time to antibiotics for another study revealed the mean time
to bolus was 31 minutes less in the post implementation group at 51 vs 82 minutes (Geoffrey et
al., 2016).
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Therefore, literature suggests that screening for sepsis provides an opportunity for early
implementation of best practices for sepsis management. These best practices include: fluid
resuscitation, antibiotics delivery, blood culture draws, and serum lactate draws.
Evidence Based Practices for Sepsis Care
Bundles and protocols.
The standard for the management of sepsis has typically utilized sepsis bundle or
protocols. A care bundle or protocol is a selected set of care interventions that are designated for
implementation when a clinical criterion threshold is met. The adoption of “sepsis bundles” or
“sepsis protocols” that standardize best practice interventions have shown significant
improvements in patient care delivery. The implementations of care bundles and protocols have
been the foundation of sepsis treatment since the initial Surviving Sepsis Campaign-evidenced
based guidelines introduction in 2004 (Dellinger et al., 2004). The guidelines have continued to
progress in the subsequent reviews of sepsis care guidelines until the most recent evaluation in
2016 (Dellinger et al., 2008; Levy MM et al., 2010; Dellinger et al., 2013; Levy MM et al., 2015;
Rhodes et al., 2015; Rhodes et al., 2017).
In the 2016 Surviving Sepsis Campaign, the evidence for each individual bundle element
was graded and evaluated for the level of evidence to support its implementation. The grades and
recommendation included, lactate level as a weak recommendation with a low quality of
evidence, the obtaining of blood cultures prior to administration of antibiotics as a best practice
statement, the administer broad-spectrum antibiotics as a strong recommendation with a
moderate quality of evidence, the rapidly administration of 30 ml/kg crystalloid for hypotension
or lactate ≥ 4 mmol/L as a strong recommendation with a low quality of evidence, and the
application vasopressors if patient is hypotensive during or after fluid resuscitation to maintain
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MAP ≥ 65 mm Hg as a strong recommendation with a moderate quality of evidence (Rhodes et
al., 2017).
Following the evaluation of evidence, recommendations were made by the Surviving
Sepsis Committee for the continued use of the following care bundles for the treatment of sepsis
within the first hours of treatment: measure lactate level and re-measure if initial lactate is > 2
mmol/L; obtain blood cultures prior to administration of antibiotics; administer broad-spectrum
antibiotics; rapidly administer 30 ml/kg crystalloid for hypotension or lactate ≥ 4 mmol/L; and
apply vasopressors if patient is hypotensive during or after fluid resuscitation to maintain
MAP ≥ 65 mm Hg. Although identified as a weak intervention in the literature, serum lactate was
included because length of time since patient presented at outside facility to receiving facility can
vary, thus some patients may have more advanced sepsis making serum lactate level an
appropriate indicator.
SIRS criteria.
The American College of Chest Physicians/Society of Critical Care Medicine established
the SIRS (systemic inflammatory response syndrome) criteria in a 1991 during a consensus
conference when tasked with developing clinical parameters for the early identification of sepsis.
The SIRS criteria identified four clinical variables to be used for the evaluation of sepsis
including: (1) a body temperature greater than 38°C or less than 36°C; (2) a heart rate greater
than 90 beats per minute; (3) tachypnea, manifested by a respiratory rate greater than 20 breaths
per minute, or hyperventilation, as indicated by a PaCO2 of less than 32 mm Hg; and (4) an
alteration in the white blood cell count, such as a count greater than 12,000/ cu mm, a count less
than 4,000/cu mm, or the presence of more than 10 percent immature neutrophils (“bands”)
(Bone et al, 1992). This criterion has been the standard definition for defining sepsis since this

7

consensus conference. However, the AMA (American Medical Association) reported in 2016
that the current standard of SIRS criteria is unanimously considered to be unhelpful. The AMA
reported that changes in white blood cell count, temperature, and heart rate reflect inflammation,
the host response to “danger” in the form of infection or other insults. The SIRS criteria do not
necessarily indicate a dysregulated, life-threatening response. SIRS criteria are present in many
hospitalized patients, including those who never develop infection and never incur adverse
outcomes (American Medical Association. 2016).
QSOFA and the development of screening tools.
The use of sepsis screening tools for early identification of sepsis has been critical to the
improvement of patient care and patient outcomes. With no validated criterion standard
diagnostic testing to confirm a diagnosis of sepsis, continual efforts have been made to identify
strategies to predict to sepsis in the early onset. Screening tools for sepsis are imperative to
properly recognize sepsis in the clinical setting and the delivery of timely care.
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
determined that new criteria for sepsis recognition was useful for the early and accurate detection
of sepsis. During the task force it was determined that qSOFA could be a useful clinical tool,
especially to physicians and other practitioners working outside the ICU (and perhaps even
outside the hospital, given that qSOFA relies only on clinical examination findings), to promptly
identify infected patients likely to fare poorly. Also, that this simple bedside score may be
particularly relevant in resource-poor settings in which laboratory data are not readily available,
and when the literature about sepsis epidemiology is sparse. The qSOFA score consists of three
clinical variables including altered mental status, a systolic blood pressure of 100 mm Hg or less,
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and a respiratory rate of 22/min or greater. The patient is considered as a high likelihood for
sepsis when two of three clinical variables are present (American Medical Association, 2017).
Synthesis
This literature review supports the pursuit of integrating a sepsis screening process using
nurses within the MARS transfer line by utilizing the American Medical Association consensus
definition for sepsis and the recommended qSOFA model for sepsis screening (American
Medical Association, 2016). The recommendation made by the American Medical Association to
utilize the qSOFA screening for the early identifications of sepsis was determined to be the most
useful screening tool for the transfer center. The simplicity of the screening and the elimination
of laboratory tests when compared to SIRS criteria made it more functional for the Throughput
RNs to complete a quick and easy assessment of transferring patients. With a varying amount of
information available during the transfer process, this simplicity and lack of need for laboratory
values is an important consideration.
The incorporation of a structured screening tool and a set of pre-determined best practice
interventions can play an important role in the early recognition of sepsis, timely delivery of best
practice interventions, and improvements in patient outcomes. Careful considerations regarding
the structure of the tools and the protocol design can influence patient outcomes. Systematic
evaluation of the implementation and evaluation of screening protocols is necessary to assess the
impact screening may have on patient outcomes. This literature review suggests that the priority
best practice interventions to incorporate in the sepsis screening process are serum lactate level
draws, blood culture draws, fluid resuscitation, vasopressor administration, and antibiotic
administration.
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Theoretical Framework.

The theoretical framework utilized for this project is the Deming Cycle or the
Plan Do Study Act (PDSA) model. This framework includes four major steps and
involves a cycle of continual improvement and evaluation. The first step of this
framework is the Plan step. The Plan step involves identifying a goal or purpose,
formulating a theory, defining success metrics, and putting a plan into action. The second Do
step is when the components of the plan are implemented. The Study step is where outcomes are
monitored to test the validity of the plan for signs of progress and success or deficits and areas
for improvement. The Act step closes the cycle by integrating the learning generated by the
entire process, which can be used to adjust the goal, or change models (The Deming Institute,
2016).
Project
Description and Design
The project involves the implementation of a screening process and a provider
consultation to guide care for sepsis patients prior to transferring to an Academic Medical
Center. The screening process was implemented through the Medical Access Referral System
(MARS) telephone line, which serves as the main hub for all transfer requests coming into the
Academic Medical Center from outside facilities. The MARS transfer line is staffed at all times
by Throughput Nurses. These Throughput Nurses are Registered Nurses responsible for triaging
and transferring all patients to the Academic Medical Center. The Throughput Nurse will screen
all adult patients referred to the MARS transfer from all referring facilities.
The screening utilizes a Quick Sequential [Sepsis-related] Organ Failure Assessment
(qSOFA) score and a serum lactate level as an indicator of sepsis. The qSOFA score has three
10

clinical variables including altered mental status, a systolic blood pressure of 100 mm Hg or less,
and a respiratory rate of 22/min or greater (American Medical Association, 2017). The patient is
considered as a high likelihood for sepsis with two of three clinical variables for the qSOFA
score and/or an elevation of a serum lactate > 4.0 mmol(36 mg/dl).
Following the screening process, the Throughput Nurse initiates the care consultation
when a qSOFA score of two or greater exists and/or an elevation of a serum lactate > 4.0
mmol(36 mg/dl) exists. If the patient does not score a two or greater and has a serum lactate level
< 4.0 mmol(36 mg/dl), the consultation will not occur and the standard pathways for patient
acceptance and admission will be completed. The care consultation process will involve direct
communication between the referring provider and a designated member of the medical team at
the Academic Medical Center via the MARS transfer phone line. Once the consultation is
completed, the patient will be accepted to an appropriate service and wait for bed placement and
patient transportation. See Appendix A for Sepsis Screening Process Algorithm
Pilot Study
A pilot study will be conducted during the first month of implementation using the PDSA
theoretical framework for evaluating the project processes. During this period one on one
interviews, meetings with Throughput RNs and consulting MDs, and a Throughput RN survey
will be completed to evaluate acceptability, practicality, and limited efficacy. Based on pilot
study changes will be made to the project (NIH, 2009).
Fit of Theoretical Framework to Project
The chosen framework works well for this planned project as it provides a solid
groundwork for a quality improvement project in a healthcare organization. It analyzes each
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stage of a change project as it would naturally occur and allows for evaluation of outcomes and
reentrance into the cycle to perfect the system change. (See Appendix B)
Feasibility Analysis
The planned project intervention is driven by current clinical guidelines repurposed for
patient transfers via the MARS transfer line. The current screening methods and consultation
process is an approved organizational process. (See Appendix A) The functional requirements
involve a software system adaptation that will integrate the sepsis screening alert into MARS
transfer process. There are no confidentiality, privacy, or security issues with the change project.
The proposed change is feasible within known technical constraints and current staff skills. The
change requires no additional demands on human resources. The change will affect the amount
of time for each MARS transfer call by an estimated 2 to 10 minutes.
Project resources.
The total costs of the project will be covered by organizational contributions. The hourly
wage contribution of the organization constitutes 98% of the of the total project costs. The hourly
wages are required for educational sessions and additional time spent during transfer calls. The
hourly wages reflect current full time employees in their current roles within the organization.
No additional personnel will be required outside of their current role for the implementation of
the project. The participation of one House Supervisor will be voluntary as they are a key
contributor to the planned project. The House Supervisor’s role is to work directly with the
Throughput Nurses to oversee patient transfers and manage bed placement. See the attached
capstone budget plan and justification (See Appendix D).

12

Organizational and project needs assessment.
The planned project utilizes current MARS line throughput nurses and on call internal
physicians working within their current roles. No additional staff will be required for the
implementation or continuation of the project. The screening process will require additional time
per MARS transfer call but it require no addition organizational workflow changes to
accommodate the additional time. The training will be completed by the MARS supervisor and
the principle project champion and will require no additional training personnel. The Throughput
nurse training sessions will be completed during their normal working hours and will require no
additional time for completion. Training for the sepsis expert consultation will occur during work
hours and will require no additional resources. (See Appendix C) The planned project reinforces
and expands the existing sepsis screening tools and sepsis protocols for care. No additional needs
are identified to implement these aspects of the project.
A strengths weaknesses opportunities and threats (SWOT) analysis was performed for
this project and indicated the strengths of this project to be interdisciplinary support for change,
support by current MARS line employees, limited financial investment necessary for change,
sepsis experts and clinical expertise within the organization, and strong leadership support for
change. The weaknesses for the project were identified as inconsistent organizational use of the
current sepsis BPA alert and sepsis protocol orders, and the potential resistance of internal care
providers. The opportunities that were identified included the organization’s positioning as the
leader of a growing health system in its state, the organization serving as the main destination for
tertiary care transfers in the state, and the organization’s strong financial positioning. The threats
to the project included external physician’s resistance to change, and the inconsistencies of
external physician’s preferences on the delivery of care.
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Congruence to the strategic plan of the organization.
WVU Medicine’s mission is to improve the health of West Virginians and all we serve
through excellence in patient care, research, and education. (WVU Medicine, 2017) The planned
project’s goals of improving the transfer process for sepsis patients and improving patient
outcomes aligns well with WVU Medicine’s mission statement. This project has the potential to
reach a large population of West Virginians through collaborative patient care strategies,
education of healthcare providers, and the research of evidence based practice application within
the organization’s health system.
The planned project aligns well with the vision of the organization. The project will seek
to expand the delivery of expert evidence based care throughout the organization’s health
system. It seeks to unify a culture of care delivery to its highest level and transform the delivery
of care so that its population can receive the right care in the right place at the right time. WVU
Medicine’s Vision is to:
Transform lives and eliminate health disparities through a nationally recognized patientcentered system of care that includes: An expanded regional healthcare delivery system,
consistent, integrated patient care recognized for delivering the right care in the right
place at the right time at all sites, development of new approaches to improve healthcare,
including team-based models of care, expanding WVU clinical and translational research,
educational programs throughout the network recognized for training uniquely qualified
healthcare team members and leaders, and a culture of performance and excellence
throughout the network (WVU Medicine, 2017).
Evidence of key site support.
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The principle stakeholders for the planned project are the MARS transfer line leadership
team. This MARS leadership team, including the Director and Manager, has offered their support
for the implementation of the project. Other key stakeholders that have offered support for the
project include the organization’s Chief Operating Officer, members of the sepsis committee, the
Director of the Center for Quality Outcomes, and the Chief Quality Officer.
Project Timeline
The planned phases of the project will begin with the Institutional Review Board process
to be completed by December 15, 2017. The education sessions for both the Throughput RNs
and sepsis consult experts will be completed by January 15, 2018. The planned project’s
intervention implementation will take place on February 1, 2018 and will be monitored for three
months through April 30, 2018. An audit and chart review of retrospective data for transferring
will be completed by March 1, 2018 to determine effectiveness and sustainability. The final
presentation of the project, including an overview and a project analysis will be conducted by
December 1, 2018. (See Appendix E)
Measurable Project Aims and Objectives
The proposed project has two main aims. These aims are, Aim 1: to evaluate the
usefulness of a new sepsis screening process and Aim 2: to evaluate the impact of the new sepsis
screening process on patient outcomes. See Table 1.
Aim 1 has three main objectives. Objective 1: the screening accurately identifies those
patients with sepsis present on arrival; AEB: A: the total number of positive screens with a
diagnosis of sepsis present on arrival(true positives), B: the total number of negative screens with
a diagnosis of sepsis present on arrival(false negatives), C: the total number of positive screens
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without a diagnosis of sepsis present on arrival(false positives), and D: the total number of
negative screens without a diagnosis of sepsis(true negatives).
For objective 1, sensitivity and specificity will be calculated using the true positive, false
negative, true negative, and false positive results. Sensitivity is calculated to measure the
proportion of actual positives that are correctly identified as such (true positives/true positives +
false negatives). Specificity is calculated to measure the proportion of actual negatives that are
correctly identified as such (true negatives/true negatives + false positives).
Objective 2: Increase the number of patients receiving Best Practices for sepsis
management, AEB: An increase the number of Best Practices implemented from initial screening
to arrival at WVU Medicine- Ruby Memorial. Objective 3: Implementation of screening will be
timely and efficient, AEB: A: the number of minutes for throughput nurse to screen for sepsis
and evaluate Best Practices and B: the number of minutes for screening to provider/transfer
connection.
Aim 2 has one main objective. Objective 1: implementation of sepsis screening process
will improve patient outcomes, AEB: A: decreased length of stay in the post-implementation
period compared to the pre-implementation period, B: decreased mortality rate in the postimplementation period compared to the pre-implementation period, and C: decreased escalation
of care prior to transfer or within the first 24 hours of admission to WVU Medicine Ruby
Memorial.
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Table 1: Measurable Project Aims and Objectives: Evaluation Plan
Aim

Objective/Criteria, AEB

Target
Population

What Data to Collect

Collection
Methods

Aim1:
Evaluate
the
usefulness
of a new
sepsis
screening
process

1. Screening accurately identifies
those patients with sepsis present
on arrival, AEB:

Nurses
Consultants
Outside
facilities
Patients
Medical
Records

Objective 1. qSOFA
scores and/or Serum
Lactate levels
compared to sepsis
diagnosis POA

Chart
Review

A. Total number of positive
screens with a diagnosis
of sepsis present on
arrival (True positives)
B. Total number of positive
screens without a
diagnosis of sepsis
present on arrival (False
positives)
C. Total number of negative
screens with a diagnosis
of sepsis present on
arrival (False negatives)
D. Total number of negative
screens without a
diagnosis of sepsis (true
negatives)

Data Analysis

Objective 1. Quantitative
analysis using descriptive
statistics, frequencies, and
Call- Miner percentage calculations
transcripts
Sensitivity and specificity
calculations using standard
formulas.
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2. Increase the number of patients
receiving Best Practices for
sepsis management, AEB:
A. Increase the number of
Best Practices
recommended during the
consultation, measured at
Time 4.
B. Increase the number of
best practice implemented
prior to arrival at WVU
Medicine- Ruby
Memorial, measured at
Time 5.

Objective 2. Best
practices (antibiotics
administered, serum
lactate drawn, fluid
resuscitation
administered, and
blood cultures drawn)
at baseline,
recommended during
the consultation
(Time 4), and
actually implemented
after the consultation
(Time 5)

Objective 2. Quantitative
analysis using descriptive
statistics, frequencies, and
percentage calculations
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3. Implementation of screening
will be timely and efficient, AEB:
A. Number of minutes for
throughput nurse to
screen for sepsis and
evaluate Best Practices
(Time 1-Time 2)
B. Number of minutes for
screening to
provider/transfer
connection (Time 2- Time
3)
Aim 2:
Evaluate
the impact
of the new
sepsis
screening
process on
patient
outcomes

Objective 1. Implementation of
sepsis screening process will
improve patient outcomes, AEB:
A. Decreased length of stay
in the postimplementation period
compared to the preimplementation period
B. Decreased mortality rate
in the postimplementation period
compared to the preimplementation period
C. Decreased escalation of
care prior to transfer or
within the first 24 hours
of admission to WVU
Medicine Ruby
Memorial.

Objective 3. Data
collected at project
time points: Time1,
Time 2, and Time 3.

Patients
pre/postprocess
implementa
tion

Objective 1. Length
of stay, mortality
rate, escalation of
care.

Objective 3. Quantitative
analysis using descriptive
statistics including frequency
and central tendency to
describe interval data.

Chart
review

Objective 1A. Quantitative
analysis using descriptive
statistics including frequency
and central tendency
comparing preimplementation interval data
(length of stay) to postimplementation interval data
(length of stay). t-test to
determine statistical difference
between the pre/ post data on
continuous variable of LOS.
Chi Square Goodness of fit test
to compare differences
between pre/post data on
categorical variables.
Objective 1B. Quantitative
analysis using descriptive
statistics including frequency
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and central tendency
comparing preimplementation nominal data
(mortality) to postimplementation nominal data
(mortality). t-test to determine
statistical difference between
the pre/ post data.
Objective 1C. Quantitative
analysis using descriptive
statistics including frequency
and central tendency
comparing preimplementation nominal data
(escalation of care) to postimplementation nominal data
(escalation of care). Chi
Square Goodness of fit test to
compare differences between
pre/post data on categorical
variables.
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Results
1270 patients were screened during the study period. The sample ages ranged from 18 to
99, including 85(6.69%) age 18-29, 82(6.46%) age 30-39, 130(10.24%) age 40-49, 233(18.35%)
age 50-59, 295(23.23%) age 60-69, 289(22.76%) age 70-79, 139(10.94%) age 80-89, and
17(1.34%) age 90-99. The majority of the screened patients were white (98.19%), 1.57% were
black, less than 1% were Asian, less than 1% were Hispanic, and less than 1% reported than
ethnicity as other. 191(15.04%) were commercially insured, 306(24.09%) were Medicaid,
757(59.61%) were Medicare, 2(0.16%) were insured through workers compensation, and
14(1.10%) were self-pay or uninsured. Screened patients were from 67 different facilities in 49
counties located throughout West Virginia, Kentucky, Virginia, Pennsylvania, and Ohio. Refer
to Table 1 for a more detailed description of the demographics. See figure 1.
Of the 1270 patients screened, 225 patients were confirmed with sepsis upon arrival to
the academic medical center. The majority of the screened patients were white (97.78%%),
1.78%% were black, less than 1% were Hispanic, are no patients reported as an ethnicity of
Asian or Other. Gender distribution of the patients was similar, 55.56% of the sample were male
and 44.44% were female. The patients with the diagnosis of sepsis present on arrival ages ranged
from 18 to 98, including 19(8.44%) age 18-29, 15(6.67%) age 30-39, 24(10.67%) age 40-49,
39(17.33%) age 50-59, 64(28.44%) age 60-69, 45(20.00%) age 70-79, 17(7.56%) age 80-89, and
2(0.89%) age 90-99. 73.33% of the patients were > the age of 50 with the largest number of
patients between the ages of 60-69. 28(12.44%) were commercially insured, 72(32.00%) were
Medicaid, 124(55.11%) were Medicare, 0 were insured through workers compensation, and
1(0.44%) were self-pay or uninsured. See Table 2.
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Figure 1

Table 2

Group Characteristic Category
White
Black
Ethnicity
Asian
Hispanic
Other
Gender
Male
Female
18-29
30-39
40-49
Age
50-59
60-69
70-79
80-89
90-99
Commercially
insured
Medicaid

Total Screened(1270) Total Sepsis POA(225)
1246(98.11%)
220(97.78%)
20(1.57%)
4(1.78%)
2(0.16%)
0(0.00%)
1(0.08%)
1(0.44%
1(0.08%)
0(0.00%
668(52.60%)
125(55.56%)
602(47.40%)
100(44.44%)
85(6.69%)
19(8.44%)
82(6.46%)
15(6.67%)
130(10.24%)
24(10.67%)
233(18.35%)
39(17.33%)
295(23.23%)
64(28.44%)
289(22.76%)
45(20.00%)
139(10.94%)
17(7.56%)
17(1.34%)
2(0.89%)
191(15.04%)
306(24.09%)

28(12.44%)
72(32.00%)
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Payor Source

Medicare
Workers
compensation
Self-pay or
uninsured

757(59.61%)

124(55.11%)

2(0.16%)

0(0.00%)

14(1.10%)

1(0.44%)

Aim1: Evaluate the Usefulness of a New Sepsis Screening Process
Objective 1.
Screening accurately identifies those patients with sepsis present on arrival, AEB: 1a. The
total number of positive screens with a diagnosis of sepsis present on arrival. 1b. The total
number of negative screens with a diagnosis of sepsis present on arrival. 1c. The total number of
positive screens without a diagnosis of sepsis present on arrival. 1d. The total number of negative
screens without a diagnosis of sepsis.
Objectives 1 A/B.
Out of 1270 patients screened for likelihood of sepsis, 159 screened high likelihood for
having sepsis, and 1111 screened likelihood of being negative for sepsis. Of the 159 screened
high likelihood, 92 had a positive diagnosis of sepsis on arrival, and 67 did not have a diagnosis
of sepsis on arrival. Thus screening accurately identified 57.9% (screened positive who were
actually positive/total number screened positive) of the “true positives” for a diagnosis of sepsis
on arrival; however, 42.1% did not have sepsis, but screened high likelihood of having sepsis, or
“false positives”.
Objectives 1 C/D.
Of the 1111 screened likelihood of being negative for sepsis, there were actually 133
patients with a positive diagnosis of sepsis (“false negative”) on arrival, and 978 did not have a
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diagnosis of sepsis on arrival (“true negatives”). Thus, 88% were appropriately screened as
negative likelihood for sepsis and did not have a diagnosis of sepsis on arrival.
From objective 1 sensitivity and specificity were calculated. Sensitivity (also called the
true positive rate) measures the proportion of actual positives that are correctly identified as such
(e.g., the percentage of patients with sepsis who are correctly identified as having sepsis).
Overall sensitivity was 40.89% (true positives/true positives + false negatives). Specificity (also
called the true negative rate) measures the proportion of actual negatives that are correctly
identified as such (e.g., the percentage of patients without sepsis who are correctly identified as
not having sepsis). Overall specificity was 93.59% (true negatives/true negatives + false
positives). Refer to Table 3 for a more detailed description of screening results.
Table 3
Total # Screened

1270

Of those screened, #of positive screens

159

Of those screened, #of negative screens

1111

Total # with diagnosis of sepsis POA

225

Of those screened positive, # with sepsis POA

92

Of those screened negative, # with sepsis POA

133

Total # without a diagnosis of sepsis POA

1045

Of those screened positive, # without sepsis POA

67

Of those screened negative, # without sepsis POA

978
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159 (11.44%) of the 225 confirmed patient with sepsis present on arrival had positive
screens. Out of that 159, 18 (11%) had a qSOFA score of 2 or greater and a serum lactate level of
4.0mmol/l (36 mg/dl) or greater, 38 (24%) patients had a serum lactate level of 4.0mmol/l (36
mg/dl) or greater alone, and 103 (65%) had a qSOFA score of 2 or greater alone.
In determining whether a screen is positive or not, a patient could have a positive qSOFA
score and/or an elevated Serum Lactate level. 159(11.44%) of the 225 confirmed patient with
sepsis present on arrival had positive screens; 18 had a qSOFA score of 2 or greater and a serum
lactate level of 4.0mmol/l(36 mg/dl) or greater, 38 patients had a serum lactate level of
4.0mmol/l(36 mg/dl) or greater alone, and 103 had a qSOFA score of 2 or greater alone. Refer to
Table 4 for a more detailed description of the screening triggers.
Table 4
Total number of positive screens

159

qSOFA score > 2 and Serum lactate >4.0mmol/l(36 mg/dl)

18

Serum lactate >4.0mmol/l(36 mg/dl) alone

38

qSOFA score > 2 alone

103

Objective 2.
Increase the number of patients receiving Best Practices for sepsis management, AEB:
2a. An increase in the number of Best Practices implemented from initial screening to arrival at
the academic medical center.
Number of best practices implemented prior to consultation.
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Of the 159 patient positive screens in the pre-consultation period (Time 2), 80(50.31%)
received fluid resuscitation, 113 (71.7%) received antibiotics, 107 (67.3%) had blood cultures
drawn, and 128 (80.50%) had a serum lactate level drawn. Of the 92 true positives for sepsis
(determined by confirmed diagnosis of sepsis POA) in the pre-consultation period, 54 (58.70%)
were receiving fluid resuscitation, 82 (89.13%) were receiving antibiotics, 68 (73.91%) had
blood cultures drawn, and 77 (83.70%) had serum lactate drawn. Refer to Table 5.
Number of best practices recommended.
Of the 92 positive screens with confirmed sepsis POA, a total of 24 best practice
recommendations were made during the consultation period, which was measured at Time 3.
This data included: 9 (9.78%) for fluid resuscitation or pressor administration, 14 (15.22%) for
antibiotic administration, and 1 (1.09%) for blood culture draws. No recommendations were
made during the consultation period for serum lactate level draws. Refer to Table 5.
Number of best practices implemented.
16 of the 24 total recommendations were confirmed as completed prior to arrival via
chart review including, 8(8.7%) of the fluid resuscitation or pressor administration
recommendations, 7(7.61%) of the antibiotic recommendations, and the 1(1.09%) blood culture
draw recommendation. Refer to Table 5.
Table 5
Best Practices Implemented Prior to Consultation

Positive Screens (159)

Fluid resuscitation/ pressor
Antibiotics
Blood cultures
Serum Lactate

80 (50.31%)
113 (71.07%)
107 (67.30%)
128 (80.50%)
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Best Practices Implemented Prior to Consultation

True Positives (92)

Fluid resuscitation/ pressor
Antibiotics
Blood cultures
Serum Lactate
Number of Best Practices Recommended

54 (58.70%)
82 (89.13%)
68 (73.91%)
77 (83.70%)
True Positives (92)

Fluid resuscitation/ pressor
Antibiotics
Blood cultures
Serum lactate
Total
Number of Best Practices Implemented

9 (9.78%)
14 (15.22%)
1 (1.09%)
0 (0.00%)
24
True Positives (92)

Fluid resuscitation/ pressor
Antibiotics
Blood cultures
Serum lactate
Unable to determine via chart review
Total confirmed via chart review

8 (8.70%)
7 (7.61%)
1 (1.09%)
0 (0.00%)
8 (8.70%)
16

Objective 3.
Implementation of screening will be timely and efficient, AEB: 3a. The number of
minutes for throughput nurse to screen for sepsis and evaluate Best Practices (Time 1 to Time2).
3b. The number of minutes for the completion of the screening to consultation connection (Time
2 to Time 3).
Of the 159 patients screening positive, times were capture for 125 patients. The mean
number of minutes for throughput nurse to screen for sepsis and evaluate Best Practices was
00:02:26 (median = 2:00; mode = 2:00; range = 1:00 – 11:00). The mean number of minutes
from screening to provider/transfer connection was 10:13 minutes (median = 6:00; mode = 4:00;
range: 1:00 – 2:11:00).
Aim 2: Evaluate the Impact of the New Sepsis Screening Process on Patient Outcomes
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Implementation of sepsis screening process will improve patient outcomes, AEB: 2a. A
decreased length of stay in the post-implementation period compared to the pre-implementation
period. 2b. A decreased mortality rate in the post-implementation period compared to the preimplementation period. 2c. A decrease in escalation of care prior to transfer or within the first 24
hours of admission to the academic medical center.
Objective 1A: LOS.
Of the 244 patients transferred with a diagnosis of sepsis present or arrival between
November 1st, 2017 and January 31st. 2018, length of stay was 12.7 days. Of the 225 patients
transferred with a diagnosis of sepsis present on arrival between February 1st, 2018 and April
30th, 2018, length of stay was 14.87 days. A 2.17 day increase in length of stay was witnessed
between the pre-implementation period and the post-implementation period. However, statistical
analysis revealed that this difference was not significant (p = .098). See Appendix F describing
statistical analysis.
Objective 1B: Mortality.
Of the 244 patients transferred with a diagnosis of sepsis present or arrival between
November 1st, 2017 and January 31st. 2018, mortality occurred in 74(30.33%) cases. Of the 225
patients transferred with a diagnosis of sepsis present on arrival between February 1st, 2018 and
April 30th, 2018, mortality occurred in 50(22.22%) cases. A decreased mortality rate of 8.11
percentage points was observed between the pre-implementation period and the postimplementation period. Statistical analysis revealed that there is a significant difference in
mortality, x2 (1, n = 225) = 6.48, p = .01. See Appendix F describing statistical analysis.
Objective 1C: EOC.
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Of the 244 patients transferred with a diagnosis of sepsis present or arrival between
November 1st, 2017 and January 31st. 2018, escalation of care occurred in 46(18.85%) cases. Of
the 225 patients transferred with a diagnosis of sepsis present on arrival between February 1st,
2018 and April 30th, 2018, escalation of care occurred in 34(15.11%) cases. A decreased
escalation of care of 3.74 percentage points was observed between the pre-implementation
period and the post-implementation period. There were no significant differences between the
pre-intervention and the post-intervention groups on EOC. See Appendix F describing statistical
analysis.
Discussion and Recommendations
Theoretical Framework
The theoretical framework utilized for this project is the D eming Cycle or the Plan
Do Study Act (PDSA) model. This framework’s four major steps were operationalized
throughout the implementation of this project. The first step of this framework is the
Plan step. The Plan step involves identifying a goal or purpose, formulating a theory, defining
success metrics, and putting a plan into action models (The Deming Institute, 2016). During the
plan phase, a literature review was completed. The key organizational stakeholders were
identified and recruited for implementation support. The project AIMs and objectives were
developed. A sepsis steering committee was formalized and organized with a focus on sepsis
treatment for patient transfers. The establishment of baseline organizational measures was
completed and the formation of key measures for the project were outlined to measure the
effectiveness of the process.
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The second Do step is when the components of the plan are implemented (The Deming
Institute, 2016). In this step, a documentation process was built within the electronic health
record system at the site of the implementation. Education sessions were completed with site
providers and Throughput RNs. Meetings were conducted with the key project stakeholders. The
sepsis screening process was then implemented during this step with a continued evaluation of
the process steps.
The Third Study step is where outcomes are monitored to test the validity of the plan for
signs of progress and success or deficits and areas for improvement (The Deming Institute,
2016). This step was utilized continually throughout the duration of the study. After 1 month of
studying the intervention, the study step was utilized via a staff survey and employee interviews.
The three lessons learned during the first month of study were a variance in the Serum Lactate
measurement, the inability to gather a GCS consistently at some outside facilities, and a varying
definition of fluid resuscitation at sending facilities. Adjustments were made based on these
finding and addressed in the next act step.
The Act step closes the cycle by integrating the learning generated by the entire process,
which can be used to adjust the goal, or change models. It was realized during the study phase
that adjustments were needed to the processes. During this phase, adjustments to the screening
process were made including Serum Lactate measurements, fluid resuscitation definitions, and
altered mental status measurements. Serum Lactate for some sending facilities was found to be
measured in mg/dL. Thus, the screening threshold for Serum Lactate was adjusted to 4mmol/L or
36 mg/dL to accommodate both measurements. The inability to consistently collect a GSC from
sending facilities was also realized. Thus, a transition of the screening to altered mental status
from GSC was made to improve the efficiency and ability of the throughput RNs to perform the
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screening. A varying definition of fluid resuscitation at sending facilities was also recognized.
An adjustment to a more detailed questioning on fluid resuscitation was made to accurately
define the exact amount of fluid received at the sending facility prior to the transfer call rather
than the previous binary response of yes or no. Following these adjustments, the processes were
then quickly cycled back into the theoretical framework for continued study. The ability for
quick rapid cycle improvements made the PDSA model idealistic for the implementation this
project.
Clinical Significance of Study Findings
The implementation of the sepsis screening process had a clinically significant impact on
this patient population. EOC: The 3.74 percentage points decrease in escalation of care decreased
the burden of resources needed to move patients between care units. An increase in the
recognition of patient’s acuity level and a subsequent prioritization in bed placement allowed for
patients to be assigned to beds earlier. The improved assignment of patients to the appropriate
level of care also allowed the appropriate care interventions to be started immediately upon
arrival to the hospital with the resources needed in place to monitor and perform care.
Mortality: The decrease in mortality of 8.11 percentage points clinical significance was
related to the placement of these patients in the correct level of care, an improvements in the
awareness of these septic patients by the Throughput RNs and Bed Coordinators that prioritized
these patients, the provider consultations that occurred, and the increase in interventions
delivered at outside facilities based on the recommendations of the providers during consultation.
Length of Stay: The 2.17 day increase in length of stay observed could be directly related
to the decrease in mortality observed in the pre/post groups. Mortality and early death in patients
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transferring with sepsis are typically linked to shorter lengths of stay. Thus, the decrease in
mortality could play a large role in these added days. The screening was also found to more
accurately identify severe sepsis cases than the less acute sepsis cases A sub analysis of the
transferring patient’s severity of illness was completed to describe the sensitivity of the screening
process for severe sepsis. The sub analysis revealed that the sepsis screening screened 58.26% of
the severe sepsis patients accurately and only 22.78% of the lower severity sepsis patients
accurately. The screenings ability to identify higher acuity cases, may have skewed the LOS
findings because less of the lower acuity level cases were recognized where LOS could be
improved significantly. A longer timeframe for data analysis could reveal more stable lengths of
stay or possibly shorter lengths of stay with the continued implementation of this process.
Recommendations for the Site
Throughout the implementation of this project, recommendations for the site were
evaluated for the continuation of this project and the potential implementation of future projects.
The Deming Cycle or the Plan Do Study Act (PDSA) model served as a successful
theoretical framework for the process implementation at the site. It would be
recommended as a beneficial theoretic framework for any future comparable project
implementation at this site.
Continuation of the project with an expansion on the screening criteria would be
recommended for the site. A recommendation for the site practice moving forward is to include
the patient’s lowest blood pressure at the sending facility instead of the most current blood
pressure. This suggestion is based on provider feedback and call analysis the recognized missed
sepsis diagnosis based on blood pressure. It was recognized that patients were being screened as
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normotensive related to fluid boluses at the time of the transfer call but they were truly
hypotensive prior to the fluid boluses and upon arrival the academic medical center.
For future project implementations, an improvement in the call management technology
would be recommended for the site. The current call management technology had limited call
data accessibility, it lacked interfacing capabilities with the electronic health record, it was
limited in the storage space needed for call retrieval, and it failed to capture periods of call data.
A lack of adherence to standing policy at the transfer center was also recognized during
the study period. During the study period adherence to the collection of standard vital signs and
mental status were not completed on 25 patients in the first month, 15 patients in the second
month, and 12 patients in the third month. Monthly call review and follow-up correspondence of
call analysis were conducted throughout the study to improve adherence. A more vigorous
schedule of call analysis, data collection, and feedback mechanism for all calls in the transfer
center would also be recommended for this site. The performance measurement frequency
recommended for the site includes an initial monthly evaluation during the change phase,
quarterly evaluations after the aim or goal is achieved, and annually following the
accomplishment of the goal and the establishment of stable performance (U.S. Department of
Health and Human Services Administration, 2011).
Recommendations for Other Settings
The project implementation would be feasible for any patient transfer center due to the
simplicity of the screening process. The project is scalable to any transfer center and the
fundamental framework could be executed at any call center without the adoption of any
technology or large expenditures. However, the project would be most effective for a similar size
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academic medical center with the available resources and expertise needed to answer the transfer
line call and provide consultation 24 hours a day and 7 days a week.
The data evaluation process utilized for this project would require specific resources that
may not be available in all other settings. A call management system or a comparable call
recording process would be an important consideration for evaluation of the process. The
electronic health record system would be a key consideration for another setting for data
capturing during the evaluation of screening scores, best practices, time stamps, and patient
outcomes evaluation. Also, a consistent technological platform and method for confirming the
admittance diagnosis of patients is essential for the evaluation of the screening tool.
Attainment of DNP Essentials
Essential I. Scientific Underpinnings for Practice.
This project demonstrates substantial content for this essential as it sought to evaluate practice
approaches from both nursing and medical evidenced based practice with underlying scientific
underpinnings to improve care delivery for this critically ill patient population. The project was
completed within a theoretic framework that guided its focus to integrate nursing and
organization science to inform the practice change.
Essential II. Organizational and Systems Leadership for Quality Improvement and
Systems Thinking.
This essential was met throughout the planning and implementation of this project. High level
stakeholders from West Virginia’s largest tertiary academic healthcare center were involved. The
project systematically involved the development of policies and protocols, organizational
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education to support policy and protocol implementation, and leading the organizational change
from beginning to end.
Essential III. Clinical Scholarship and Analytical Methods for Evidence-Based Practice.
During the implementation of this project, a thorough review of the literature and an analysis of
evidenced based practices was completed to inform the practice change. The examination of the
evidence informed the development of the project, the establishment of measures, and
mechanisms for evaluating the project outcomes.
Essential IV. Information Systems/Technology and Patient Care Technology for the
Improvement and Transformation of Health Care
This essential was used for all aspects of this project. The project required the use of three major
IT systems for implementation and evaluation. During the implementation of this project two
database builds were required for evaluation and a process was built within the electronic health
record to complete the project’s implementation. This use of IT was imperative to design this
project and the ability of the project to improve the delivery of care for these patients.
Essential V. Health Care Policy for Advocacy in Health Care.
This project required a thorough evaluation of the organizations existing policies and
collaboration with decision makers in the organization for a new policy implementation. A new
policy was then designed and implemented that directed that practice change. From a broader
standpoint, Federal regulations as defined by CMS recently added sepsis patient care to publicly
reportable information with an ultimate link to hospital reimbursement.
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Essential VI. Interprofessional Collaboration for Improving Patient and Population Health
Outcomes.
This project required many disciplines to become stakeholders and participants in the process
change. Physicians, Pharmacists, Researchers, Nurses, Administrators, Advanced Practice
Professionals, and Executive leadership were pivotal to the successful completion of the
development and implementation of the project. This essential was exemplified through the
leadership of this interdisciplinary team to successfully implement this change project.
Essential VII. Clinical Prevention and Population Health for Improving the Nation’s
Health.
This project met this essential by focusing on the sepsis population and improving the health of
these patients by influencing and incorporating a new care delivery model. Beyond the
immediate academic health center, it serves a tertiary care center population through a significant
region that may have improvements in health secondary to the implementation of this project.
The new care delivery model served a region including 67 different facilities in 49 counties
located throughout West Virginia, Kentucky, Virginia, Pennsylvania, and Ohio.
Essential VIII. Advanced Nursing Practice.
This essential was met through the assessment of a complex health situation and disease state
and the design and implementation of an intervention to meet the needs of these patients. This
required leading a healthcare team to change their practice, analysis of the complex results for
clinical significance, and continual quality improvement of the practice change.
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Appendix A
Sepsis Screening Process Algorithm

1. An outside facility provider contacts the WVU Medicine MARS
transfer line requesting a patient transfer.

2. The WVU Medicine sepsis screening process is initiated through a
series of questions asked by the Throughput RN including the 4
following criteria:
QSOFA
A. Altered Mental Status: GCS < 15 = 1 point
➢ “Does the patient have an altered mental
status?”
B. Respiratory Rate > 22 breaths per minute = 1 point
➢ “What is the patient’s current respiratory rate?”
C. Systolic Blood Pressure < 100 mm Hg = 1 point
➢ “What is the patient’s current blood pressure?”
Serum Lactate
A. Serum Lactate Level > 4 mmol/L(36mg/dL)
➢ “What is the patient’s serum lactate level?”

WVU Medicine QSOFA score > 2 points and/or Serum Lactate
Level > 4 mmol/L(36mg/dL) l: Continue to step 4

WVU Medicine QSOFA score < 2 points and Serum
Lactate Level < 4 mmol/L(36mg/dL): Sepsis screening
process stop

3. The Throughput RN evaluates the total WVU Medicine QSOFA
score and a serum lactate level to determine a need for the sepsis
consultation. Each QSOFA criterion has a value of 1 point

4. The Throughput RN evaluates if the 4 following best practices
have been implemented.
A.

B.

C.
D.

Fluid resuscitation at 30ml/kg/ Vasopressor
administration
➢ “Has the patient received fluid resuscitation
or Vasopressor administration?”
➢ “If yes, what specific fluids or vasopressor?”
Antibiotic administration
➢ “Has the patient received antibiotics?”
➢ “If yes, what antibiotics have been
administered?”
Blood culture draws
➢ “Have blood cultures been drawn?”
Serum Lactate level draw (if not already known)
➢ “Has a lactate level been drawn?”
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5. The Throughput RN contacts the WVU Medicine attending provider
via the MARS transfer phone line.

6. The Throughput RN conveys the 4 best practices implementation
status to the WVU Medicine attending provider.

7. The Throughput RN connects the WVU Medicine attending provider
with the outside facility provider via the MARS transfer line.

8. The WVU Medicine attending provider guides care to ensure that the
following 4 best practices are completed as indicated:
A.
B.
C.
D.

Fluid resuscitation at 30ml/kg/ Vasopressor
administration
Antibiotic administration
Blood culture draws
Serum Lactate level drawn

9. The Throughput RN completes the bed request.

10. The patient arrives to WVU Medicine- Ruby Memorial.
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Appendix B
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Appendix C
Sepsis Screening Process Education
 What is a WVU Medicine QSOFA screen?
o The “QSOFA” acronym stands for:
▪ Q-uick
▪ S-epsis Related Organ
▪ O-rgan
▪ F-ailure
▪ A-ssessment
 What are the variables of a WVU Medicine QSOFA screen?
o Altered Mental Status: GCS < 13 = 1 point
▪ “What is the patient’s current GCS?”
o Respiratory Rate > 22 breaths per minute = 1 point
▪ “What is the patient’s current respiratory rate?”
o Systolic Blood Pressure < 100 mm Hg = 1 point
▪ “What is the patient’s current blood pressure?”
o Serum Lactate Level > 4 mmol/ l = 1 point
▪ “What is the patient’s serum lactate level?”
 How is a WVU Medicine QSOFA screen scored?
o Each variable has a value of 1 point
o A WVU Medicine QSOFA score < 2 points: Negative screen and the sepsis
expert consultation is not indicated.
o A WVU Medicine QSOFA score > 2 points: Positive screen and the sepsis
expert consultation is indicated.
 Who is performing the WVU Medicine QSOFA screening?
o The WVU Medicine MARS line Throughput RNs.
 When is the WVU Medicine QSOFA screen taking place?
o During the patient information collection period at the onset of an adult patient
transfer call from an outside facility.
 What is WVU Medicine QSOFA screen replacing and why?
o What- QSOFA is replacing SIRS criteria screening.
o Why- According to the American Medical Association previous SIRS definitions
included:
▪ An excessive focus on inflammation
▪ A misleading model that follows a continuum through severe sepsis to
shock
▪ An inadequate specificity and sensitivity
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▪

Multiple definitions and terminologies that lead to discrepancies in
reported incidence and observed mortality

 What are the priority interventions of the Sepsis Consultation?
o Fluid resuscitation/ Vasopressor administration
▪ “Has the patient received fluid resuscitation or Vasopressor
administration?”
o Antibiotic administration
▪ “Has the patient received antibiotics?”
▪ “If yes, what antibiotics have been administered?”
o Blood culture draws
▪ “Have blood cultures been drawn?”
o Serum Lactate level draw
▪ “Has a lactate level been drawn?”
 When and how is the Sepsis Consultation initiated?
o When- Following the collection of a patient transfer’s information when a WVU
Medicine QSOFA score > 2 points exists
o How- A MARS telephone line connection is made between the sending provider
and the attending physician.
 What internal providers are serving as the Sepsis Consultants?
o All on-call attending providers and fellows for their respective WVU Medicine
services.
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Appendix D
Budget Categories

Personal Funds

Organizational Contributions

$0

$6,760

ADMINISTRATIVE COSTS

Administrative Justification: Education of Throughput RN staff is essential for successful
integration of this process change. The education will be performed by 2 House supervisors
over a period of 2 total hours at approximately $40 per hour= $160. Educational sessions will
occur over a 1 hour period for 10 Throughput RNs at approximately $30 per hour= $300. The
education will be supplementary to current organizational workflow and will be an
organizational contribution. Throughout the projects implementation period of 3 months,
there will be an additional 2 to 10 minutes per call for an average daily call volume of 50 calls
(estimated 45 calls at 2 minutes and 5 calls at 10 minutes) conducted by Throughput RN staff
at an approximate $30= ($1x45 calls/ $5x5 calls) $6,300. The added time spent during each
phone call will occur as an additional step during normal workflow and will be an
organizational contribution.
Marketing

$0

$0

Marketing Justification:
EDUCATIONAL MATERIALS/
INCENTIVES

$0

$50

Educational Materials/Incentives Justification: Materials needed for successful education and
continued support of change process through provided reference materials. Materials needed
include paper, posters, lamination sheets, and printer ink.
HOSPITALITY (food, room rentals,
etc.)

$0

$50

Hospitality Justification: Refreshments for education sessions
PROJECT SUPPLIES (office
supplies, postage, printing, etc.)

$0

$100

Project Supplies Justification: Current facility supplies already in place include computers,
phones, and office space. Additional supplies needed including paper, folders, lamination
sheets, printer ink, and 3 ring binders will be necessary as references to continually support
the change.
TRAVEL EXPENSES

$0

$0

Travel Expenses Justification:
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OTHER

$0

$0

Other Justification:
TOTALS

$0

$6,960
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Appendix E

Sep-17Oct-17Nov-17Dec-17Jan-18Feb-18Mar-18Apr-18May-18Jun-18 Jul-18 Aug-18Sep-18Oct-18Nov-18Dec-18
Present Project Proposal to Committee

Project presentation to WVU Medicine Sepsis Commitee

IRB final process

Complete EPIC build for Throughput Nurse documentation

Hold Education session with consultation MDs

Hold Education sessions with Throughput RNs

Project Implementation

Retrospective data via chart review

DNP project presentation to WVU School of nursing
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Appendix F
Statistics

Question guiding the statistical analysis:
•

How does the pre-intervention group differ from the post-intervention group on length of stay
(LOS), escalation of care (EOC), and mortality?
o

H1:

o

H2:

Compared to the pre-intervention group, the post-intervention group will have
an increase in LOS.
Compared to the pre-intervention group, the post-intervention group will have
a decrease in EOC and in mortality.

Descriptive statistics were run on the variables of LOS, EOC, and mortality in both the pre- and postintervention groups. Data were screened for missing data, incorrect values, and outliers. Table 1
presents descriptive data on these variables.
Table 1: Descriptive data on LOS, EOC, and mortality
Group
Pre-Intervention
N = 244
Post-Intervention
N = 225

LOS
Mean: 12.77 days
Median: 9 days
Mode: 1 day
Mean: 14.84 days
Median: 10 days
Mode: 3 days

EOC
EOC Yes = 46
EOC No = 198

Mortality
Yes = 74
No = 170

EOC Yes = 34
EOC No = 191

Yes = 50
No = 175

Length of Stay (LOS)
To test H1, an independent samples t-test was used to compare the pre-intervention group to the postintervention group on LOS. There were no significant differences in scores for the pre-intervention
group (M = 12.77, SD = 12.33) and the post-intervention group (M = 14.84, SD = 14.54); t (441) = -1.66, p
= .098, two tailed). The magnitude of the difference in the means (mean difference = 2.07, 95% CI: -4.53
to 0.39) was very small (eta squared = .006). See Table 2 for output.
The Levene’s test showed that the variances of the two groups are not the same (p = .018), thus the
SPSS output of equal variances not assumed was used, and showed a non-significant difference (p =
.098) between the two group on LOS.
The descriptive statistics showed that LOS increased by 2.07 days in the post-intervention group. In
assessing for outliers, 91% of the cases in the pre-intervention group had a LOS of 32 days or less. The
range of the remaining 9% was from 33-70 days. For the post-intervention group, 91% of the cases had a
LOS of 38 days or less, with the remaining 9% having a range of 39-84 days.
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Escalation of Care (EOC) and Mortality
To test H2, a one-sample chi-square analysis was used to compare the proportion of cases in the postintervention group with those obtained previously from a comparison sample (the pre-intervention
group). The expected values for EOC obtained from the pre-intervention group was 19%; the expected
value for mortality was 30%.
A chi-square goodness-of-fit test indicates that there are not significant differences between the preintervention and the post-intervention groups on EOC (15.5% compared to 18.9% in the preintervention group) [x2 (1, n = 225) = 2.21, p = .14]; however, there are significant differences in
mortality (22.2% compared to 30% in the pre-intervention group), x2 (1, n = 225) = 6.48, p = .01. See
Table 3 for output.
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